Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2230548 | 0.86 | CYP2C19 (0.39) | CYP2C19KMT2ALMNAHSD17B10ALDH1A1 | |
| SCHEMBL9246620 | 0.81 | ALDH1A1 (0.34) | CYP2C19KMT2AALDH1A1 | |
| SCHEMBL9579111 | 0.80 | HMGCR (0.33) | CYP2C19KMT2AHMGCRCHRM1TBXA2R | |
| Methacrylic Acid SCHEMBL3685758 | 0.80 | TSHR (0.45) | ALDH1A1TSHR | |
| SCHEMBL7699054 | 0.79 | CYP2C19 (0.35) | CYP2C19KMT2ALMNAHSD17B10ALDH1A1 | |
| SCHEMBL4557040 | 0.78 | SERPINE1 (0.32) | — | |
| SCHEMBL320683 | 0.78 | — | — | |
| SCHEMBL9245957 | 0.77 | ALDH1A1 (0.33) | CYP2C19KMT2ALMNAHSD17B10ALDH1A1 | |
| SCHEMBL7790728 | 0.77 | CYP2C19 (0.33) | CYP2C19KMT2ALMNAHSD17B10 | |
| SCHEMBL8317343 | 0.77 | ALDH1A1 (0.31) | CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115434076-B | Biodegradable nonwoven fabric | 三井化学旭生活材料有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-113518710-A | Laminated foam sheet | 积水化成品工业株式会社 | 2021-10-19 | — | — | CN | disclosed |
| CN-113508019-A | Process for producing biodegradable resin foamed sheet | 积水化成品工业株式会社 | 2021-10-15 | — | — | CN | disclosed |
| EP-3042961-B1 | METHOD FOR PRODUCING OLIGOMER AND/OR MONOMER BY DEGRADING BIODEGRADABLE RESIN | TOYO SEIKAN KAISHA LTD (JP) | 2021-05-19 | — | — | EP | disclosed |
| WO-2020201935-A1 | BIODEGRADABLE POLYESTER-BASED RESIN EXPANDED PARTICLE, METHOD FOR PRODUCING BIODEGRADABLE POLYESTER-BASED RESIN EXPANDED PARTICLE, BIODEGRADABLE POLYESTER-BASED RESIN EXPANDED MOLDED ARTICLE, AND METHOD FOR PRODUCING BIODEGRADABLE POLYESTER-BASED RESIN EXPANDED MOLDED ARTICLE | 積水化成品工業株式会社 | 2020-10-08 | — | — | WO | disclosed |
| WO-2020194198-A1 | LAMINATED FOAM SHEET | 積水化成品工業株式会社 | 2020-10-01 | — | — | WO | disclosed |
| CN-107106818-B | Wire member | 郡是株式会社 | 2020-06-16 | — | — | CN | disclosed |
| EP-3042961-A1 | METHOD FOR PRODUCING OLIGOMER AND/OR MONOMER BY DEGRADING BIODEGRADABLE RESIN | Toyo Seikan Kaisha, Ltd. (JP) | 2016-07-13 | — | — | EP | disclosed |
| EP-2348122-B1 | METHOD FOR PRODUCING OLIGOMER AND/OR MONOMER BY DEGRADING BIODEGRADABLE RESIN | TOYO SEIKAN KAISHA LTD (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-9284432-B2 | Method for degrading a readily-degradable resin composition | TOYO SEIKAN KAISHA, LTD. (JP) | 2016-03-15 | — | — | US | disclosed |
| EP-2348122-A1 | METHOD FOR PRODUCING OLIGOMER AND/OR MONOMER BY DEGRADING BIODEGRADABLE RESIN | Toyo Seikan Kaisha, Ltd. (JP) | 2011-07-27 | — | — | EP | disclosed |
| EP-1221439-B1 | TETRAHYDROQUINOLINE DERIVATIVES | KAKEN PHARMA CO LTD (JP) | 2007-01-03 | — | — | EP | disclosed |
| US-7037919-B1 | Tetrahydroquinoline derivatives | KAKEN PHARMACEUTICAL CO. LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| US-6777427-B2 | SPECIFIC AND STRONG BINDING AFFINITY FOR ANDROGEN RECEPTORS AND EXHIBIT ANDROGEN RECEPTOR AGONISM OR ANTAGONISM | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20030216428-A1 | Tetrahydroquinoline compounds | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2003-11-20 | — | — | US | disclosed |
| EP-1325914-A1 | TETRAHYDROQUINOLINE COMPOUNDS | Kaken Pharmaceutical Co., Ltd. (JP) | 2003-07-09 | — | — | EP | disclosed |
| EP-1221439-A1 | TETRAHYDROQUINOLINE DERIVATIVES | Kaken Pharmaceutical Co., Ltd. (JP) | 2002-07-10 | — | — | EP | disclosed |
| EP-0731198-B1 | Biodegradable filament nonwoven fabrics and method of manufacturing the same | UNITIKA LTD (JP) | 2002-05-08 | — | — | EP | disclosed |
| US-5688582-A | Biodegradable filament nonwoven fabrics and method of manufacturing the same | UNITIKA LTD. (JP) | 1997-11-18 | — | — | US | disclosed |
| EP-0731198-A2 | Biodegradable filament nonwoven fabrics and method of manufacturing the same | UNITIKA LTD. (JP) | 1996-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216428-A1 | Tetrahydroquinoline compounds | AR, MUSK, NR5A1 | CYP2C19 1646/4885KMT2A 2983/4885LMNA 2649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.